A Safety and Immunogenicity Study of 3 Doses of Opal Immunotherapy in HIV Infected People
Clinical trial NCT01123915 · TERMINATED
Trial details
- NCT number
- NCT01123915
- Sponsor
- Medicines Development for Global Health
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-05-01
- Primary completion
- 2011-12-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.